MIT -Massachusetts Institute of Technology – experts visited Vetanco

Following the signing of a Memorandum of Understanding/Cooperation Agreement (MOU) between the MIT startup Sunflower and Bioinnovo, Kerry Love, PhD [...]

Bioinnovo, Algenex reinforce vaccine molecule Arrangement

Argentina’s Bioinnovo has updated its partnership with Spanish firm Algenex for the use of a [...]

First R&D team meeting

Last Tuesday Nov. 26rd a corporate meeting of the R&D international teams of Dr Bata, BV Science, Vetanco and Bioinnovo was held [...]

Bioinnovo and Algenex renew agreement for the use of APCH

Bioinnovo, the technology-based public-private company formed by the National Institute of Agricultural Technology (INTA) and [...]

Jeffrey W. Hall at the CRWAD 2019 in Chicago

On November 3, Jeffrey W. Hall presented our latest news on developments in mucosal immunity [...]

Maria Arendt Dashek, spent a training week in BV Science

Maria, who started last week to work for BV Science, the company based in St Louis [...]

Recognition of Dysantic

BV Science is proud to announce that Hungarian Innovation Society awarded an innovation grand prize diploma our Dysantic. This [...]

BV Science on continuous expansion

Besides our operation in Saint Louis, USA, we are adding more production and logistic capacity [...]

Vetanco USA, Inc. welcomes Jeffrey W. Hall, Ph.D. as our new Research and Development Director

Jeffrey W. Hall will be our Research and Development Director in the USA directly reporting to Dr. Sherry [...]

Sherry Layton, closing keynote at the 3rd edition of the Animal Microbiome Congress Europe

Sherry Layton, Ph.D., Chief Scientific Officer for BV Science will give the Closing Keynote presentation at the [...]